(Health-NewsWire.Net, May 20, 2016 ) Publisher's, 'Chagas Disease (American Trypanosomiasis) - Pipeline Review, H1 2016', provides an overview of the Chagas Disease (American Trypanosomiasis) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Chagas Disease (American Trypanosomiasis), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Chagas Disease (American Trypanosomiasis) and features dormant and discontinued projects.
Publisher's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.
Other Key Points in Report:
- The report provides a snapshot of the global therapeutic landscape of Chagas Disease (American Trypanosomiasis) - The report reviews pipeline therapeutics for Chagas Disease (American Trypanosomiasis) by companies and universities/research institutes based on information derived from company and industry-specific sources - The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved Chagas Disease (American Trypanosomiasis) therapeutics and enlists all their major and minor projects - The report assesses Chagas Disease (American Trypanosomiasis) therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
Inquire before Purchasing Report @ http://www.reportsweb.com/inquiry&RW0001239336/buying
Reasons to Buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of therapeutics under development for Chagas Disease (American Trypanosomiasis) - Identify potential new clients or partners in the target demographic - Develop strategic initiatives by understanding the focus areas of leading companies - Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics - Devise corrective measures for pipeline projects by understanding Chagas Disease (American Trypanosomiasis) pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Ask for Sample Report @ http://www.reportsweb.com/inquiry&RW0001239336/sample
Table of Content: An Overview
Introduction 9 Publisher Report Coverage 9 Chagas Disease (American Trypanosomiasis) Overview 10 Therapeutics Development 11 Pipeline Products for Chagas Disease (American Trypanosomiasis) - Overview 11 Pipeline Products for Chagas Disease (American Trypanosomiasis) - Comparative Analysis 12 Chagas Disease (American Trypanosomiasis) - Therapeutics under Development by Companies 13 Chagas Disease (American Trypanosomiasis) - Therapeutics under Investigation by Universities/Institutes 14 Chagas Disease (American Trypanosomiasis) - Pipeline Products Glance 15 Late Stage Products 15 Clinical Stage Products 16 Early Stage Products 17 Chagas Disease (American Trypanosomiasis) - Products under Development by Companies 18 Chagas Disease (American Trypanosomiasis) - Products under Investigation by Universities/Institutes 19 Chagas Disease (American Trypanosomiasis) - Companies Involved in Therapeutics Development 21 Anacor Pharmaceuticals, Inc. 21 Bayer AG 22 Eisai Co., Ltd. 23 GlaxoSmithKline Plc 24
Ask for Discount on Report @ http://www.reportsweb.com/inquiry&RW0001239336/discount
Grupo Praxis Pharmaceutical SA 25 KaloBios Pharmaceuticals, Inc. 26 Merck & Co., Inc. 27 Panacela Labs, Inc. 28 Sanofi 29 SEEK Group 30 Chagas Disease (American Trypanosomiasis) - Therapeutics Assessment 31 Assessment by Monotherapy Products 31 Assessment by Target 32 Assessment by Mechanism of Action 34 Assessment by Route of Administration 36 Assessment by Molecule Type 38 Drug Profiles 40 benznidazol - Drug Profile 40 Product Description 40 Mechanism of Action 40 R&D Progress 40 benznidazole - Drug Profile 41 Product Description 41 Mechanism of Action 41 R&D Progress 41 chagas disease (bivalent) vaccine - Drug Profile 42 Product Description 42 Mechanism of Action 42 R&D Progress 42 chagas disease vaccine - Drug Profile 43 Product Description 43 Mechanism of Action 43 R&D Progress 43 chagas disease vaccine - Drug Profile 44 Product Description 44 Mechanism of Action 44 R&D Progress 44 chagas disease vaccine - Drug Profile 45 Product Description 45 Mechanism of Action 45 R&D Progress 45
Purchase Complete Report @ http://www.reportsweb.com/buy&RW0001239336/buy/2000
About Us:
ReportsWeb.com is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries.
Contact Us: Email: sales@reportsweb.com Call: +1-646-491-9876
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com
|